CATALOGO DEI PRODOTTI DELLA RICERCA

LAWLOR, Rita Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.262
NA - Nord America 3.811
AS - Asia 1.960
AF - Africa 72
SA - Sud America 23
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.152
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.775
CN - Cina 1.315
GB - Regno Unito 1.224
IT - Italia 926
IE - Irlanda 425
SE - Svezia 383
FR - Francia 348
RU - Federazione Russa 322
SG - Singapore 283
DE - Germania 271
FI - Finlandia 143
VN - Vietnam 126
HK - Hong Kong 64
UA - Ucraina 56
TG - Togo 48
KR - Corea 41
JO - Giordania 35
BE - Belgio 33
JP - Giappone 26
CA - Canada 25
NL - Olanda 24
AT - Austria 19
AU - Australia 18
CZ - Repubblica Ceca 14
TR - Turchia 13
BF - Burkina Faso 12
IN - India 12
ES - Italia 10
IR - Iran 10
PL - Polonia 9
CL - Cile 8
BR - Brasile 7
BG - Bulgaria 6
LV - Lettonia 6
CH - Svizzera 5
GR - Grecia 5
KG - Kirghizistan 5
MA - Marocco 5
PA - Panama 5
CO - Colombia 4
IL - Israele 4
LU - Lussemburgo 4
MY - Malesia 4
PK - Pakistan 4
RO - Romania 4
AZ - Azerbaigian 3
LT - Lituania 3
MK - Macedonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
BO - Bolivia 2
BZ - Belize 2
CR - Costa Rica 2
CY - Cipro 2
EG - Egitto 2
EU - Europa 2
IS - Islanda 2
LK - Sri Lanka 2
MD - Moldavia 2
MX - Messico 2
NG - Nigeria 2
PE - Perù 2
RS - Serbia 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
HR - Croazia 1
ID - Indonesia 1
PT - Portogallo 1
SI - Slovenia 1
TW - Taiwan 1
Totale 10.152
Salva come PNG Salva come JPEG
Città #
Southend 1.154
Chandler 945
Verona 457
Dublin 392
Beijing 313
Jacksonville 245
Ann Arbor 213
Ashburn 202
Singapore 191
Woodbridge 182
New York 168
Lawrence 134
Princeton 134
Wilmington 129
Jinan 122
Houston 96
Nanjing 91
Redmond 87
Shenyang 87
Dong Ket 82
Sindelfingen 66
Hebei 65
Helsinki 63
Hong Kong 58
Zhengzhou 53
Lomé 48
Seattle 45
Haikou 39
Ningbo 36
Amman 35
Tianjin 35
Changsha 34
Taizhou 34
Brussels 33
Nanchang 33
Jiaxing 32
Hangzhou 30
Redwood City 30
Washington 30
Dallas 29
Milan 28
Dearborn 27
Guangzhou 27
Seoul 27
Taiyuan 27
Bologna 23
Kent 21
Lappeenranta 19
Los Angeles 19
Tokyo 18
Vienna 18
Boardman 16
Chicago 16
Chions 16
Lancaster 16
Fairfield 15
Norwalk 15
Fuzhou 13
Munich 13
Bobo-Dioulasso 12
Brno 12
Falls Church 12
Sydney 12
Shanghai 11
Buffalo 10
Pieve di Soligo 10
Lanzhou 9
San Francisco 9
Amsterdam 8
Dongguan 8
Naples 8
San Jose 8
Toronto 8
Bolzano 7
Falkenstein 7
Villafranca Di Verona 7
Moscow 6
Padova 6
Riga 6
Rome 6
Trieste 6
Ajax 5
Bishkek 5
Brescia 5
Clearwater 5
Düsseldorf 5
Illasi 5
Kemerovo 5
London 5
Palermo 5
Poznan 5
San Diego 5
Sofia 5
Suwon 5
Auburn Hills 4
Bogotá 4
Boydton 4
Bressanone 4
Cagliari 4
Casier 4
Totale 6.903
Salva come PNG Salva come JPEG
Nome #
Common Minimum Technical Standards and Protocols for Biobanks Dedicated to Cancer Research 249
Whole-genome landscape of pancreatic neuroendocrine tumours 163
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples 155
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. 141
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 138
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 131
1177PUndiscovered immune heterogeneity in pancreatic adenocarcinoma (PDAC) 129
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 128
Genomic analyses identify molecular subtypes of pancreatic cancer 127
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 123
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 121
Reporting tumor molecular heterogeneity in histopathological diagnosis 120
RON is not a prognostic marker for resectable pancreatic cancer 118
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients 110
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 108
Genomic characterization of hepatoid tumors: context matters 107
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 106
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 103
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors 101
Lost in translation: returning germline genetic results in genome-scale cancer research 100
CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas 99
International network of cancer genome projects 97
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 97
Research capacity. Enabling the genomic revolution in Africa 95
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 95
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 94
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies 94
Ampulla of Vater carcinoma: Molecular landscape and clinical implications 91
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 88
Urine Metabolic Signature of Pancreatic Ductal Adenocarcinoma by (1)H Nuclear Magnetic Resonance: Identification, Mapping, and Evolution 88
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 86
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 86
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 85
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 85
Gα15 in early onset of pancreatic ductal adenocarcinoma 84
428OImmune landscape of pancreatic neuroendocrine tumours (PanNETs) 84
Splice variants as novel targets in pancreatic ductal adenocarcinoma 83
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes 82
Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma 82
Biosampling and biobanking (Chapter7) 82
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 82
A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk 80
Hypermutation In Pancreatic Cancer 79
Whole genomes redefine the mutational landscape of pancreatic cancer 78
Building capacity for sustainable research programmes for cancer in Africa 78
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer 78
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 78
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms 76
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 76
Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling 75
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 75
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 74
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 73
Combined microRNA and mRNA microfluidic TaqMan array cards for the diagnosis of malignancy of multiple types of pancreatico-biliary tumors in fine-needle aspiration material 71
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations 70
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 70
Exosomal miRNA signatures of pancreatic lesions 70
New genomic landscapes and therapeutic targets for biliary tract cancers 69
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 69
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 68
Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary 68
Comparative Lesions Analysis Through a Targeted Sequencing Approach 68
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival 67
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 67
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 67
Whole-exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1 65
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 65
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation 64
Sex differences in oncogenic mutational processes 64
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 64
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome 63
Biospecimens and Biobanking in Global Health 63
The Italian Rare Pancreatic Exocrine Cancer Initiative 63
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study 62
A Model of Collaboration ad Experiences between Bio-industry and Academic Biobanks 61
Germline BRCA2 K3326X and CHEK2 I157T Mutations Increase Risk for Sporadic Pancreatic Ductal Adenocarcinoma 61
Reduced risk of pancreatic cancer associated with asthma and nasal allergies 60
The Global Genome Biodiversity Network (GGBN) Data Standard specification 60
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 60
Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes 59
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis 58
Combinatorial Effect of Magnetic Field and Radiotherapy in Pancreatic Ductal Adenocarcinoma Organoids 58
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation 58
European, Middle Eastern, and African Society for Biopreservation and Biobanking (ESBB). 2012 Conference Session on Biobanking in Emerging Countries 57
Genome-wide association study identifies an early onset pancreatic cancer risk locus 56
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 56
Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology 56
Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients 55
Pan-cancer analysis of whole genomes 55
Endoscopic ultrasound guided fine needle biopsy samples to drive personalized medicine: A proof of concept study 54
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients 54
Biobanks in Low Resource Contexts 53
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities 53
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 53
Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case-control approaches 52
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 51
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 51
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma 51
A multimodality test to guide the management of patients with a pancreatic cyst 50
The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperation 50
Totale 8.196
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.065
article - articoli 39.634
book - libri 497
conference - conferenze 661
curatela - curatele 0
other - altro 568
patent - brevetti 0
selected - selezionate 0
volume - volumi 705
Totale 84.130
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020817 0 0 35 22 99 85 123 54 39 102 125 133
2020/20211.260 180 187 75 179 140 110 35 24 43 45 90 152
2021/20221.318 127 354 75 114 52 33 54 90 51 32 81 255
2022/20232.624 160 320 203 439 219 619 45 165 291 35 89 39
2023/20241.877 57 124 125 168 177 330 95 192 56 129 305 119
2024/2025805 298 285 222 0 0 0 0 0 0 0 0 0
Totale 10.559